AMICOSANTE, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 28.989
EU - Europa 2.555
AS - Asia 987
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 7
AF - Africa 5
OC - Oceania 3
Totale 32.554
Nazione #
US - Stati Uniti d'America 28.977
DE - Germania 1.038
SG - Singapore 486
UA - Ucraina 387
CN - Cina 359
IE - Irlanda 254
IT - Italia 193
FR - Francia 162
RU - Federazione Russa 134
SE - Svezia 106
FI - Finlandia 92
GB - Regno Unito 88
KR - Corea 85
PL - Polonia 27
RO - Romania 27
IN - India 17
BE - Belgio 15
JP - Giappone 11
BG - Bulgaria 10
KG - Kirghizistan 9
CA - Canada 8
EU - Europa 8
BR - Brasile 5
NL - Olanda 4
VN - Vietnam 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
ES - Italia 3
HK - Hong Kong 3
TH - Thailandia 3
DM - Dominica 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
IS - Islanda 2
MX - Messico 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BF - Burkina Faso 1
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
TW - Taiwan 1
ZM - Zambia 1
Totale 32.554
Città #
Woodbridge 9.446
Wilmington 7.870
Houston 7.299
Ann Arbor 714
Fairfield 655
Singapore 408
Jacksonville 373
Ashburn 314
Chandler 310
Seattle 277
Dublin 244
Cambridge 219
Medford 186
Beijing 168
Dearborn 152
New York 93
Lawrence 88
Santa Clara 79
Menlo Park 63
Rome 54
Zhengzhou 53
Guangzhou 29
Milan 29
Mülheim 27
San Diego 27
Kraków 25
Norwalk 20
Boardman 16
Nanjing 15
Brussels 14
Falls Church 14
Moscow 14
Mountain View 14
Palo Alto 13
Hefei 12
Shanghai 12
University Park 12
San Mateo 11
Verona 11
Redwood City 9
Sofia 9
Helsinki 7
Mcallen 7
Nanchang 7
Detroit 6
Pune 6
Auburn Hills 5
Fuzhou 5
Hangzhou 5
Indiana 5
Kunming 5
London 5
Saint Petersburg 5
Anagni 4
Munich 4
San Francisco 4
Toronto 4
Xian 4
Bangkok 3
Brno 3
Dong Ket 3
Madrid 3
Nanning 3
Nuremberg 3
Quzhou 3
Shaoxing 3
Ahmedabad 2
Anderson 2
Aprilia 2
Auckland 2
Bologna 2
Central 2
Chengdu 2
Chongqing 2
Cormano 2
Creede 2
Forest City 2
Harbin 2
Hebei 2
Herzliya 2
Jinan 2
Kalyani 2
Los Angeles 2
Montréal 2
Nova Milanese 2
Nuoro 2
Nürnberg 2
Parma 2
Pilis 2
Prescot 2
Roseau 2
Sacramento 2
Shenyang 2
State College 2
The Dalles 2
Tianjin 2
Veracruz 2
Washington 2
Yellow Springs 2
Aigaleo 1
Totale 29.577
Nome #
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study 501
HLA-A, -B and -DRB1 allele frequencies in Cyrenaica population (Libya) and genetic relationships with other populations 469
B-Pred, a structure based B-cell epitopes prediction server 460
Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model 453
Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection 451
Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy 450
HS1,2 Ig Enhancer Alleles Association to AIDS Progression in a Pediatric Cohort Infected with a Monophyletic HIV-Strain 449
Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection 439
Role of individual's T cell immunome in controlling HIV-1 progression 431
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 424
M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis 414
Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay 413
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability 411
Metodo per la diagnosi in vitro di fibrosi polmonare/polmonite interstiziale idiopatica e uso di chelanti del ferro per il trattamento della fibrosi polmonare/polmonite interstiziale idiopatica 410
An outbreak of Q fever in Bulgaria 408
Amino Acid Mutations in Ebola Virus Glycoprotein of the 2014 epidemic 408
A model of phenotypic susceptibility to tuberculosis: Deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles 407
Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants 405
Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom 405
null 405
Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins 405
Human Leucocyte Antigen Class I Diversity among Human Immunodeficiency Virus Exposed Negative and Positive Children in Cameroon. 405
Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport 403
Expansion of pre-terminally differentiated CD8 T cells in chronic HIV-positive patients presenting a rapid viral rebound during structured treatment interruption 401
Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy 400
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 399
Key role of human leukocyte antigen in modulating HIV progression: an overview of the possible applications. 399
Reactivity to mycobacterial antigens by patients with Lofgren's syndrome as a model of phenotypic susceptibility to disease and disease progression. 397
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 396
Genetic diversity in Ebola virus: Phylogenetic and in silico structural studies of Ebola viral proteins 396
Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test 395
Impact of human leukocyte antigen polymorphisms in human immunodeficiency virus progression in a paediatric cohort infected with a mono-phyletic human immunodeficiency virus-1 strain 394
Dynamics of the laboratory results in patients with pulmonary tuberculosis. 393
Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69 391
HLA class II amino acid epitopes as susceptibility markers of sarcoidosis 391
Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection 388
Evaluation of a western blot test as a potential screening tool for occupational exposure to Mycobacterium tuberculosis in health care workers 387
Evaluation of the BDProbeTec strand displacement amplification assay in comparison with the AMTD II direct test for rapid diagnosis of tuberculosis 385
Different cytokine production and effector/memory dynamics of alpha beta+ or gamma delta+ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis 381
Cross-reactive CD4+ T cells against one immunodominant tumor-derived epitope in melanoma patients 381
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study 380
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak 378
Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction 377
HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells 372
HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children 370
Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model 369
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 367
IGRAs for tuberculosis in sarcoidosis patients: is the immune response to mycobacteria helpful in the differential diagnosis or still a confounding factor? 367
Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression 367
Evaluation of a novel tuberculosis complex-specific 34 kDa protein in the serological diagnosis of tuberculosis 367
Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity 366
Metal-induced diffuse lung disease 365
Uso di peptidi marcatori di sopravvivenza di Mycobacterium tuberculosis per la diagnosi e la prevenzione di infezione tubercolare e relativo kit diagnostico. 365
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers 364
Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis 363
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak 362
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 360
Sensitivity and specificity of a multi-antigen ELISA test for the serological diagnosis of tuberculosis 360
Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages 357
Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding 355
Synthetic peptides for use in the diagnosis and therapy of chronic granulomatous beryllium disease 352
Beryllium disease 352
Peptidi antigenici per uso diagnostico e di vaccinazione anti-tubercolare 350
Uso di sequenze amminoacidiche da Mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino 346
Method of antigenic peptide identification and relative use for the preparation of a vaccine anti HIV-1 346
Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis 344
Antibody repertoire against the A60 antigen complex during the course of pulmonary tuberculosis 343
Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69 342
Computer-based design of an HLA-haplotype and HIV-clade independent cytotoxic T-lymphocyte assay for monitoring HIV-specific immunity 341
Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection 340
[Mycobacterium tuberculosis. From the gene to the diagnosis] 338
Evaluation of a multi-antigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis 337
Major histocompatibility locus genetic markers of beryllium sensitization and disease 336
Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients 335
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin 328
Rapid immunological test for the diagnosis and monitoring of tuberculosis infection. 326
[Berylliosis in Italy: a case of "sarcoidosis" under the threshold limit value] 323
Seroprevalence of Ebola virus infection in Bombali district, Sierra Leone 321
Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection 317
Method for in vitro diagnosis of idiopathic pulmonary fibrosis 310
Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies. 299
Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells 296
T cell recognition in chronic beryllium disease 295
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. 291
Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease 285
Metodo e test diagnostici basati sull’analisi citofluorimetrica dei linfociti T antigene-specifici. 235
Occurrence of Legionella in showers at recreational facilities 149
Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns 101
Current use and acceptability of novel diagnostic tests for active tuberculosis: A worldwide survey|Uso atual e aceitabilidade de novos testes diagnósticos para tuberculose ativa: Um inquérito mundial 80
HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis 46
Totale 32.635
Categoria #
all - tutte 55.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.697 0 0 0 0 740 884 739 798 708 739 494 595
2020/20214.677 498 564 497 646 432 490 659 472 112 83 187 37
2021/2022790 30 82 22 59 21 92 43 40 52 59 65 225
2022/2023886 105 57 29 106 70 246 93 42 74 1 43 20
2023/2024299 50 6 17 12 17 105 7 2 21 4 2 56
2024/2025865 80 433 219 93 40 0 0 0 0 0 0 0
Totale 32.635